News
Dr. Trevejo discusses the importance of diversity in clinical trials and the non-viral gene therapy we are developing against COVID-19
Watch as our CEO Dr. Trevejo discusses the importance of diversity in clinical trials and the non-viral gene therapy we are developing to treat infection with Coronavirus. Watch now on CityLine. [...]
Sorrento Therapeutics and SmartPharm Therapeutics Announce Intention to Collaborate to Develop Novel Gene-Encoded Antibody Vaccine Intended for COVID-19 GallerySorrento Therapeutics and SmartPharm Therapeutics Announce Intention to Collaborate to Develop Novel Gene-Encoded Antibody Vaccine Intended for COVID-19
Sorrento Therapeutics and SmartPharm Therapeutics Announce Intention to Collaborate to Develop Novel Gene-Encoded Antibody Vaccine Intended for COVID-19
For Immediate Release March 23, 2020 SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19 Collaboration to leverage synergies between Monoclonal Antibody and Non-Viral Gene [...]
SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors
CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of John T. Potts, [...]
SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum
SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum CAMBRIDGE, Mass., Oct. 16, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the [...]
SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference
SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference CAMBRIDGE, Mass. – September 30, 2019 – SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies [...]
SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors
SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors Published: Sep 05, 2019 CAMBRIDGE, Mass., Sept. 5, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene [...]